These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11252650)

  • 1. Calcium channel antagonists for the treatment of bipolar disorder.
    Levy NA; Janicak PG
    Bipolar Disord; 2000 Jun; 2(2):108-19. PubMed ID: 11252650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.
    Cipriani A; Saunders K; Attenburrow MJ; Stefaniak J; Panchal P; Stockton S; Lane TA; Tunbridge EM; Geddes JR; Harrison PJ
    Mol Psychiatry; 2016 Oct; 21(10):1324-32. PubMed ID: 27240535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].
    Sarfati Y; Spadone C; Vanelle JM; Lôo H
    Encephale; 1996; 22(2):149-53. PubMed ID: 8706625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
    Mallinger AG; Thase ME; Haskett R; Buttenfield J; Luckenbaugh DA; Frank E; Kupfer DJ; Manji HK
    Bipolar Disord; 2008 Dec; 10(8):856-66. PubMed ID: 19594501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of randomized controlled trials of lithium monotherapy.
    Severus WE; Kleindienst N; Greil W
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):519-20; author reply 521. PubMed ID: 17042892
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
    Amrollahi Z; Rezaei F; Salehi B; Modabbernia AH; Maroufi A; Esfandiari GR; Naderi M; Ghebleh F; Ahmadi-Abhari SA; Sadeghi M; Tabrizi M; Akhondzadeh S
    J Affect Disord; 2011 Mar; 129(1-3):327-31. PubMed ID: 20843556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):35-47. PubMed ID: 30558453
    [No Abstract]   [Full Text] [Related]  

  • 10. Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.
    Davanzo PA; Krah N; Kleiner J; McCracken J
    J Child Adolesc Psychopharmacol; 1999; 9(1):51-61. PubMed ID: 10357518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000206. PubMed ID: 10796323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine.
    Solomon GD
    Headache; 1985 Oct; 25(7):368-71. PubMed ID: 3908401
    [No Abstract]   [Full Text] [Related]  

  • 13. A new BALANCE in bipolar I disorder.
    Licht RW
    Lancet; 2010 Jan; 375(9712):350-2. PubMed ID: 20092883
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review.
    Post RM; Frye MA; Denicoff KD; Leverich GS; Dunn RT; Osuch EA; Speer AM; Obrocea G; Jajodia K
    Bipolar Disord; 2000 Dec; 2(4):305-15. PubMed ID: 11252642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On being bipolar without being bipolar.
    Goldberg J
    J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives for clinical research on bipolar disorders in the new millennium.
    Goodwin G
    Bipolar Disord; 2000 Dec; 2(4):302-4. PubMed ID: 11252641
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
    Leon MB; Rosing DR; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.